{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T19:25:27Z","timestamp":1773948327862,"version":"3.50.1"},"reference-count":93,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2018,7,30]],"date-time":"2018-07-30T00:00:00Z","timestamp":1532908800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006545","name":"National Institute on Minority Health and Health Disparities","doi-asserted-by":"publisher","award":["G12 MD 007582"],"award-info":[{"award-number":["G12 MD 007582"]}],"id":[{"id":"10.13039\/100006545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006545","name":"National Institute on Minority Health and Health Disparities","doi-asserted-by":"publisher","award":["P20 MD 006738"],"award-info":[{"award-number":["P20 MD 006738"]}],"id":[{"id":"10.13039\/100006545","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0201116","type":"journal-article","created":{"date-parts":[[2018,7,30]],"date-time":"2018-07-30T13:29:45Z","timestamp":1532957385000},"page":"e0201116","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":28,"title":["The inhibitory effects of plumbagin on the NF-\u049bB pathway and CCL2 release in racially different triple-negative breast cancer cells"],"prefix":"10.1371","volume":"13","author":[{"given":"Samia S.","family":"Messeha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Najla O.","family":"Zarmouh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Mendonca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayfaa","family":"Alwagdani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malak G.","family":"Kolta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0600-1085","authenticated-orcid":true,"given":"Karam F. A.","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,7,30]]},"reference":[{"issue":"1","key":"ref1","first-page":"31","article-title":"Breast cancer statistics, 2015: Convergence of incidence rates between black and white women","volume":"66","author":"CE DeSantis","year":"2016","journal-title":"CA: a cancer journal for clinicians"},{"issue":"1","key":"ref2","first-page":"7","article-title":"Cancer statistics, 2018","volume":"68","author":"RL Siegel","year":"2018","journal-title":"CA: a cancer journal for clinicians"},{"issue":"Suppl 2","key":"ref3","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.3816\/CBC.2009.s.008","article-title":"Biology, metastatic patterns, and treatment of patients with triple-negative breast cancer","volume":"9","author":"CK Anders","year":"2009","journal-title":"Clinical breast cancer"},{"issue":"40","key":"ref4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.7748\/ns.25.40.49.s50","article-title":"Treatment, and care of patients with metastatic breast cancer","volume":"25","author":"T Beaumont","year":"2011","journal-title":"Nursing standard (Royal College of Nursing (Great Britain): 1987)"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ctrv.2009.10.001","article-title":"Novel therapeutic approaches to the treatment of metastatic breast cancer","volume":"36","author":"Y Fernandez","year":"2010","journal-title":"Cancer treatment reviews"},{"issue":"7","key":"ref6","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1038\/bjc.2013.534","article-title":"Disulfiram targets cancer stem-like cells and reverses resistance and cross-resistance in acquired paclitaxel-resistant triple-negative breast cancer cells","volume":"109","author":"P Liu","year":"2013","journal-title":"British journal of cancer"},{"issue":"14","key":"ref7","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1093\/jnci\/djp175","article-title":"Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group","volume":"101","author":"KS Albain","year":"2009","journal-title":"Journal of the National Cancer Institute"},{"issue":"3","key":"ref8","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1365-2796.2000.00742.x","article-title":"Infections as a major preventable cause of human cancer","volume":"248","author":"H Kuper","year":"2000","journal-title":"Journal of internal medicine"},{"issue":"4","key":"ref9","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/ncb1559","article-title":"Oestrogen 3signaling inhibits invasive phenotype by repressing RelB and its target BCL2","volume":"9","author":"X Wang","year":"2007","journal-title":"Nature cell biology"},{"issue":"21","key":"ref10","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1200\/JCO.2008.18.9068","article-title":"Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients","volume":"27","author":"BL Pierce","year":"2009","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"5","key":"ref11","doi-asserted-by":"crossref","first-page":"a000141","DOI":"10.1101\/cshperspect.a000141","article-title":"NF-kappaB as a critical link between inflammation and cancer","volume":"1","author":"M Karin","year":"2009","journal-title":"Cold Spring Harbor perspectives in biology"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s11882-012-0300-5","article-title":"Role of nuclear factor-kB in breast and colorectal cancer","volume":"13","author":"A Zubair","year":"2013","journal-title":"Current allergy and asthma reports"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrc780","article-title":"NF-kappaB in cancer: from innocent bystander to major culprit","volume":"2","author":"M Karin","year":"2002","journal-title":"Nature Reviews Cancer"},{"issue":"1\u20132","key":"ref14","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11010-009-0267-2","article-title":"NF-kappaB and cancer: how intimate is this relationship","volume":"336","author":"S Prasad","year":"2010","journal-title":"Molecular and cellular biochemistry"},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1172\/JCI11914","article-title":"Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer","volume":"107","author":"Y Yamamoto","year":"2001","journal-title":"The Journal of clinical investigation"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13287-015-0080-7","article-title":"Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-alpha and the NF-kappaB pathway","volume":"6","author":"C Katanov","year":"2015","journal-title":"Stem cell research & therapy"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.gde.2008.01.003","article-title":"Pathways connecting inflammation and cancer","volume":"18","author":"P Allavena","year":"2008","journal-title":"Current opinion in genetics & development"},{"issue":"12","key":"ref18","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1038\/bjc.1998.373","article-title":"Association of tumour necrosis factor alpha and its receptors with thymidine phosphorylase expression in invasive breast carcinoma","volume":"77","author":"RD Leek","year":"1998","journal-title":"British journal of cancer"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3389\/fimmu.2014.00614","article-title":"Molecular mechanisms that influence the macrophage m1-m2 polarization balance","volume":"5","author":"N Wang","year":"2014","journal-title":"Frontiers in immunology"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1210\/me.2011-1302","article-title":"Minireview: Inflammation: an instigator of more aggressive estrogen receptor (ER) positive breast cancers","volume":"26","author":"SC Baumgarten","year":"2012","journal-title":"Molecular endocrinology (Baltimore, Md)"},{"issue":"6","key":"ref21","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.biopha.2009.04.032","article-title":"Gene expression of the invasive phenotype of TNF-alpha-treated MCF-7 cells","volume":"63","author":"Y Yin","year":"2009","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"issue":"3","key":"ref22","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s10555-006-9005-3","article-title":"TNF-alpha in promotion and progression of cancer","volume":"25","author":"F Balkwill","year":"2006","journal-title":"Cancer metastasis reviews"},{"issue":"4","key":"ref23","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1084\/jem.169.4.1485","article-title":"Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line","volume":"169","author":"K Matsushima","year":"1989","journal-title":"The Journal of experimental medicine"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cytogfr.2009.11.009","article-title":"CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis","volume":"21","author":"J Zhang","year":"2010","journal-title":"Cytokine & growth factor reviews"},{"issue":"14","key":"ref25","doi-asserted-by":"crossref","first-page":"7176","DOI":"10.1158\/0008-5472.CAN-06-0825","article-title":"Chemokine (C-C motif) ligand 2 mediates the prometastatic effect of dysadherin in human breast cancer cells","volume":"66","author":"JS Nam","year":"2006","journal-title":"Cancer research"},{"issue":"9","key":"ref26","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.3109\/13880200903433760","article-title":"Antimicrobial activities of neo- and 1-epineo-isoshinanolones from Plumbago zeylanica roots","volume":"48","author":"A Jetty","year":"2010","journal-title":"Pharmaceutical biology"},{"issue":"4","key":"ref27","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1179\/135100004225005976","article-title":"Antioxidant properties of Plumbago zeylanica, an Indian medicinal plant and its active ingredient, plumbagin","volume":"9","author":"JC Tilak","year":"2004","journal-title":"Redox report: communications in free radical research"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.mrgentox.2015.06.004","article-title":"Plumbagin alters telomere dynamics, induces DNA damage and cell death in human brain tumour cells","volume":"793","author":"AK Khaw","year":"2015","journal-title":"Mutation research Genetic toxicology and environmental mutagenesis"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/1472-6882-11-114","article-title":"Modulation of T cell proliferation and cytokine response by Plumbagin, extracted from Plumbago zeylanica in collagen induced arthritis","volume":"11","author":"A Poosarla","year":"2011","journal-title":"BMC complementary and alternative medicine"},{"key":"ref30","article-title":"The attenuating effects of plumbagin on pro-inflammatory cytokine expression in LPS-activated BV-2 microglial cells","author":"SS Messeha","year":"2017","journal-title":"Journal of neuroimmunology"},{"issue":"1","key":"ref31","first-page":"30","article-title":"Plumbagin shows anti-cancer activity in human breast cancer cells by the upregulation of p53 and p21 and suppression of G1 cell cycle regulators","volume":"37","author":"XQ Zhang","year":"2016","journal-title":"European journal of gynaecological oncology"},{"issue":"21","key":"ref32","doi-asserted-by":"crossref","first-page":"9024","DOI":"10.1158\/0008-5472.CAN-08-2494","article-title":"Plumbagin, a medicinal plant-derived naphthoquinone, is a novel inhibitor of the growth and invasion of hormone-refractory prostate cancer","volume":"68","author":"MH Aziz","year":"2008","journal-title":"Cancer research"},{"issue":"6","key":"ref33","doi-asserted-by":"crossref","first-page":"709","DOI":"10.2174\/1567201812666150316150033","article-title":"Plumbagin Nanoparticles Induce Dose and pH Dependent Toxicity on Prostate Cancer Cells","volume":"12","author":"HA Nair","year":"2015","journal-title":"Current drug delivery"},{"issue":"4","key":"ref34","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/annonc\/mdm557","article-title":"Estrogen-dependent cell signaling and apoptosis in BRCA1-blocked BG1 ovarian cancer cells in response to plumbagin and other chemotherapeutic agents","volume":"19","author":"KA Thasni","year":"2008","journal-title":"Annals of oncology: official journal of the European Society for Medical Oncology"},{"key":"ref35","first-page":"537","article-title":"Plumbagin induces cell cycle arrest and autophagy and suppresses epithelial to mesenchymal transition involving PI3K\/Akt\/mTOR-mediated pathway in human pancreatic cancer cells","volume":"9","author":"F Wang","year":"2015","journal-title":"Drug design, development and therapy"},{"issue":"2a","key":"ref36","first-page":"785","article-title":"Anticancer mechanism of plumbagin, a natural compound, on non-small cell lung cancer cells","volume":"28","author":"R Gomathinayagam","year":"2008","journal-title":"Anticancer research"},{"issue":"5","key":"ref37","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1049\/iet-nbt.2015.0008","article-title":"Plumbagin-silver nanoparticle formulations enhance the cellular uptake of plumbagin and its antiproliferative activities","volume":"9","author":"P Appadurai","year":"2015","journal-title":"IET nanobiotechnology"},{"issue":"4","key":"ref38","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/mc.20031","article-title":"Plumbagin induces reactive oxygen species, which mediate apoptosis in human cervical cancer cells","volume":"40","author":"P Srinivas","year":"2004","journal-title":"Molecular carcinogenesis"},{"issue":"3","key":"ref39","doi-asserted-by":"crossref","first-page":"R79","DOI":"10.1186\/bcr3192","article-title":"Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat","volume":"14","author":"CR Tate","year":"2012","journal-title":"Breast cancer research: BCR"},{"issue":"8","key":"ref40","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/sj.bjc.6600872","article-title":"Cooperation between monocytes and breast cancer cells promotes factors involved in cancer aggressiveness","volume":"88","author":"E Blot","year":"2003","journal-title":"British journal of cancer"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2147\/DDDT.S118485","article-title":"Theophylline action on primary human bronchial epithelial cells under proinflammatory stimuli and steroidal drugs: a therapeutic rationale approach","volume":"11","author":"L Gallelli","year":"2017","journal-title":"Drug design, development and therapy"},{"issue":"5534","key":"ref42","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1126\/science.1062677","article-title":"Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway","volume":"293","author":"U Senftleben","year":"2001","journal-title":"Science (New York, NY)"},{"issue":"2","key":"ref43","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S1097-2765(01)00187-3","article-title":"NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100","volume":"7","author":"G Xiao","year":"2001","journal-title":"Molecular cell"},{"issue":"5","key":"ref44","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"D Hanahan","year":"2011","journal-title":"Cell"},{"issue":"5381","key":"ref45","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1126\/science.281.5381.1312","article-title":"Caspases: enemies within","volume":"281","author":"NA Thornberry","year":"1998","journal-title":"Science (New York, NY)"},{"issue":"2","key":"ref46","first-page":"139","article-title":"Overview of cell death signaling pathways","volume":"4","author":"Z Jin","year":"2005","journal-title":"Cancer biology & therapy"},{"issue":"2","key":"ref47","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/0006-291X(89)92366-8","article-title":"Monocyte chemotactic protein gene expression by cytokine-treated human fibroblasts and endothelial cells","volume":"162","author":"RM Strieter","year":"1989","journal-title":"Biochemical and biophysical research communications"},{"issue":"6","key":"ref48","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1084\/jem.171.6.2177","article-title":"Properties of monocyte chemotactic and activating factor (MCAF) purified from a human fibrosarcoma cell line","volume":"171","author":"CO Zachariae","year":"1990","journal-title":"The Journal of experimental medicine"},{"issue":"17","key":"ref49","doi-asserted-by":"crossref","first-page":"5020","DOI":"10.1158\/1078-0432.CCR-07-0731","article-title":"Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells","volume":"13","author":"RM Dwyer","year":"2007","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"issue":"43","key":"ref50","doi-asserted-by":"crossref","first-page":"36593","DOI":"10.1074\/jbc.M112.365999","article-title":"CCL2\/CCR2 chemokine signaling coordinates survival and motility of breast cancer cells through Smad3 protein- and p42\/44 mitogen-activated protein kinase (MAPK)-dependent mechanisms","volume":"287","author":"WB Fang","year":"2012","journal-title":"The Journal of biological chemistry"},{"issue":"9","key":"ref51","first-page":"15684","article-title":"Expression of CCL2 is significantly different in five breast cancer genotypes and predicts patient outcome","volume":"8","author":"J Wang","year":"2015","journal-title":"International journal of clinical and experimental medicine"},{"issue":"7355","key":"ref52","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature10138","article-title":"CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis","volume":"475","author":"BZ Qian","year":"2011","journal-title":"Nature"},{"issue":"7525","key":"ref53","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/nature13862","article-title":"Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis","volume":"515","author":"L Bonapace","year":"2014","journal-title":"Nature"},{"issue":"1","key":"ref54","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11060-010-0473-5","article-title":"Systemic delivery of neutralizing antibody targeting CCL2 for glioma therapy","volume":"104","author":"X Zhu","year":"2011","journal-title":"Journal of neuro-oncology"},{"issue":"5","key":"ref55","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1593\/neo.10200","article-title":"Loss of transforming growth factor-beta signaling in mammary fibroblasts enhances CCL2 secretion to promote mammary tumor progression through macrophage-dependent and -independent mechanisms","volume":"12","author":"SL Hembruff","year":"2010","journal-title":"Neoplasia (New York, NY)"},{"issue":"1","key":"ref56","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1182\/blood.V96.1.34","article-title":"Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression","volume":"96","author":"R Salcedo","year":"2000","journal-title":"Blood"},{"issue":"11","key":"ref57","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1593\/neo.09988","article-title":"The chemokine CCL2 increases prostate tumor growth and bone metastasis through macrophage and osteoclast recruitment","volume":"11","author":"K Mizutani","year":"2009","journal-title":"Neoplasia (New York, NY)"},{"issue":"2\u20133","key":"ref58","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.imlet.2003.12.009","article-title":"Impact of tumor-derived CCL2 on T cell effector function","volume":"91","author":"PF Vitiello","year":"2004","journal-title":"Immunology letters"},{"issue":"3","key":"ref59","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10555-006-9001-7","article-title":"Role of tumor-associated macrophages in tumor progression and invasion","volume":"25","author":"A Mantovani","year":"2006","journal-title":"Cancer metastasis reviews"},{"issue":"11","key":"ref60","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1158\/0008-5472.CAN-11-3567","article-title":"CCL2 mediates cross-talk between cancer cells and stromal fibroblasts that regulates breast cancer stem cells","volume":"72","author":"A Tsuyada","year":"2012","journal-title":"Cancer research"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"2925869","DOI":"10.1155\/2017\/2925869","article-title":"Targeting Signaling Pathways in Cancer Stem Cells for Cancer Treatment","volume":"2017","author":"J Koury","year":"2017","journal-title":"Stem cells international"},{"issue":"11","key":"ref62","doi-asserted-by":"crossref","first-page":"5681","DOI":"10.21873\/anticanres.11151","article-title":"Targeting Cellular Signaling Pathways in Breast Cancer Stem Cells and its Implication for Cancer Treatment","volume":"36","author":"BR Pires","year":"2016","journal-title":"Anticancer research"},{"issue":"5","key":"ref63","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/1097-0142(20010901)92:5<1085::AID-CNCR1424>3.0.CO;2-K","article-title":"Significant correlation of monocyte chemoattractant protein-1 expression with neovascularization and progression of breast carcinoma","volume":"92","author":"H Saji","year":"2001","journal-title":"Cancer"},{"issue":"8","key":"ref64","first-page":"3282","article-title":"Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer","volume":"6","author":"T Ueno","year":"2000","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"issue":"4","key":"ref65","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.coph.2004.04.004","article-title":"Tumor necrosis factor-alpha in the pathogenesis and treatment of cancer","volume":"4","author":"GM Anderson","year":"2004","journal-title":"Current opinion in pharmacology"},{"issue":"6","key":"ref66","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s10585-012-9473-5","article-title":"Targeting monocyte chemotactic protein-1 synthesis with bindarit induces tumor regression in prostate and breast cancer animal models","volume":"29","author":"M Zollo","year":"2012","journal-title":"Clinical & experimental metastasis"},{"issue":"7","key":"ref67","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/carcin\/bgp127","article-title":"Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability","volume":"30","author":"F Colotta","year":"2009","journal-title":"Carcinogenesis"},{"issue":"4","key":"ref68","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2174\/156652410791316968","article-title":"Molecular pathways linking inflammation and cancer","volume":"10","author":"A Mantovani","year":"2010","journal-title":"Current molecular medicine"},{"issue":"10\u201312","key":"ref69","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.bbagrm.2010.05.004","article-title":"Inhibiting NF-kappaB activation by small molecules as a therapeutic strategy","volume":"1799","author":"SC Gupta","year":"2010","journal-title":"Biochimica et biophysica acta"},{"issue":"3\u20134","key":"ref70","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s00439-006-0315-x","article-title":"Genetic variation in tumor necrosis factor and lymphotoxin-alpha (TNF-LTA) and breast cancer risk","volume":"121","author":"MM Gaudet","year":"2007","journal-title":"Human genetics"},{"issue":"6","key":"ref71","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/ijc.2910560603","article-title":"Expression of tumour necrosis factor (TNF alpha) and its receptors in benign and malignant breast tissue","volume":"56","author":"DW Miles","year":"1994","journal-title":"International journal of cancer"},{"issue":"36","key":"ref72","doi-asserted-by":"crossref","first-page":"5006","DOI":"10.1038\/onc.2010.260","article-title":"The unexpected role of lymphotoxin beta receptor signaling in carcinogenesis: from lymphoid tissue formation to liver and prostate cancer development","volume":"29","author":"MJ Wolf","year":"2010","journal-title":"Oncogene"},{"issue":"9","key":"ref73","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nri1184","article-title":"Signalling pathways of the TNF superfamily: a double-edged sword","volume":"3","author":"BB Aggarwal","year":"2003","journal-title":"Nature reviews Immunology"},{"issue":"6","key":"ref74","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1002\/ijc.28458","article-title":"Cytokine and cytokine receptor genes of the adaptive immune response are differentially associated with breast cancer risk in American women of African and European ancestry","volume":"134","author":"L Quan","year":"2014","journal-title":"International journal of cancer"},{"issue":"12","key":"ref75","doi-asserted-by":"crossref","first-page":"e82519","DOI":"10.1371\/journal.pone.0082519","article-title":"Four genetic polymorphisms of lymphotoxin-alpha gene and cancer risk: a systematic review and meta-analysis","volume":"8","author":"Y Huang","year":"2013","journal-title":"PloS one"},{"issue":"19","key":"ref76","doi-asserted-by":"crossref","first-page":"10057","DOI":"10.1073\/pnas.94.19.10057","article-title":"Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control","volume":"94","author":"ZL Chu","year":"1997","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"3","key":"ref77","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1161\/01.RES.88.3.282","article-title":"xIAP induces cell-cycle arrest and activates nuclear factor-kappaB: new survival pathways disabled by caspase-mediated cleavage during apoptosis of human endothelial cells","volume":"88","author":"B Levkau","year":"2001","journal-title":"Circulation research"},{"issue":"53","key":"ref78","doi-asserted-by":"crossref","first-page":"8568","DOI":"10.1038\/sj.onc.1207101","article-title":"The inhibitors of apoptosis: there is more to life than Bcl2","volume":"22","author":"P Liston","year":"2003","journal-title":"Oncogene"},{"issue":"1","key":"ref79","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1471-4906(00)01814-7","article-title":"Caspases: more than just killers?","volume":"22","author":"M Los","year":"2001","journal-title":"Trends in immunology"},{"issue":"12","key":"ref80","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1158\/1535-7163.MCT-06-0478","article-title":"Plumbagin induces G2-M arrest and autophagy by inhibiting the AKT\/mammalian target of rapamycin pathway in breast cancer cells","volume":"5","author":"PL Kuo","year":"2006","journal-title":"Molecular cancer therapeutics"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13058-015-0640-x","article-title":"Expression of functional toll like receptor 4 in estrogen receptor\/progesterone receptor-negative breast cancer","volume":"17","author":"M Mehmeti","year":"2015","journal-title":"Breast cancer research: BCR"},{"issue":"31","key":"ref82","doi-asserted-by":"crossref","first-page":"E2110","DOI":"10.1073\/pnas.1209414109","article-title":"MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response","volume":"109","author":"M Fabbri","year":"2012","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"ref83","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.yexmp.2014.05.003","article-title":"Toll-like receptor (TLR) expression of immune system cells from metastatic breast cancer patients with circulating tumor cells","volume":"97","author":"TL Green","year":"2014","journal-title":"Experimental and molecular pathology"},{"issue":"24","key":"ref84","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.4161\/15384101.2014.989947","article-title":"Cell-intrinsic TLR2\/MyD88 pathway in breast and colon cancer","volume":"13","author":"AH Kuo","year":"2014","journal-title":"Cell cycle (Georgetown, Tex)"},{"issue":"1","key":"ref85","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/cdd.2011.158","article-title":"BCL2A1: the underdog in the BCL2 family","volume":"19","author":"M Vogler","year":"2012","journal-title":"Cell death and differentiation"},{"issue":"11","key":"ref86","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.1073\/pnas.1205575110","article-title":"BCL2A1 is a lineage-specific antiapoptotic melanoma oncogene that confers resistance to BRAF inhibition","volume":"110","author":"R Haq","year":"2013","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"4","key":"ref87","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1158\/1078-0432.CCR-08-0144","article-title":"Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy","volume":"15","author":"MH Kang","year":"2009","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"issue":"41","key":"ref88","doi-asserted-by":"crossref","first-page":"14710","DOI":"10.1073\/pnas.1408556111","article-title":"ICAM-1 as a molecular target for triple negative breast cancer","volume":"111","author":"P Guo","year":"2014","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"4","key":"ref89","doi-asserted-by":"crossref","first-page":"e0175558","DOI":"10.1371\/journal.pone.0175558","article-title":"Apigenin inhibits TNFalpha\/IL-1alpha-induced CCL2 release through IKBK-epsilon signaling in MDA-MB-231 human breast cancer cells","volume":"12","author":"D Bauer","year":"2017","journal-title":"PloS one"},{"issue":"6","key":"ref90","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.cell.2007.03.052","article-title":"Integrative genomic approaches identify IKBKE as a breast cancer oncogene","volume":"129","author":"JS Boehm","year":"2007","journal-title":"Cell"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.cbi.2016.08.021","article-title":"Elevated IL-1beta expression induces invasiveness of triple negative breast cancer cells and is suppressed by zerumbone","volume":"258","author":"M Jeon","year":"2016","journal-title":"Chemico-biological interactions"},{"issue":"2","key":"ref92","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.3390\/molecules20023406","article-title":"Anti-proliferative effect and induction of apoptosis in androgen-independent human prostate cancer cells by 1,5-bis(2-hydroxyphenyl)-1,4-pentadiene-3-one","volume":"20","author":"K Citalingam","year":"2015","journal-title":"Molecules (Basel, Switzerland)"},{"key":"ref93","doi-asserted-by":"crossref","first-page":"276946","DOI":"10.1155\/2015\/276946","article-title":"1,2,3,4,6-Penta-O-galloylglucose within Galla Chinensis Inhibits Human LDH-A and Attenuates Cell Proliferation in MDA-MB-231 Breast Cancer Cells","volume":"2015","author":"S Deiab","year":"2015","journal-title":"Evidence-based complementary and alternative medicine: eCAM"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0201116","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T10:16:25Z","timestamp":1571652985000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0201116"}},"subtitle":[],"editor":[{"given":"Aamir","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,7,30]]},"references-count":93,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2018,7,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0201116","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,30]]}}}